% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I4210163497&score_min=67
% 14 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{ossenkoppele2015-25988463,
  author  = {Ossenkoppele, R. and Jansen, W. J. and Rabinovici, G. D. and Knol, D. L. and van der Flier, W. M. and van Berckel, B. N. and Scheltens, P. and Visser, P. J. and others},
  title   = {{Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis}},
  journal = {JAMA},
  year    = {2015},
  doi     = {10.1001/jama.2015.4669},
  pmid    = {25988463},
  url     = {https://doi.org/10.1001/jama.2015.4669}
}

@article{honig2018-29365294,
  author  = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others},
  title   = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1705971},
  pmid    = {29365294},
  url     = {https://doi.org/10.1056/nejmoa1705971}
}

@article{ostrowitzki2022-36121669,
  author  = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others},
  title   = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2909},
  pmid    = {36121669},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2909}
}

@article{bateman2023-37966285,
  author  = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others},
  title   = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2304430},
  pmid    = {37966285},
  url     = {https://doi.org/10.1056/nejmoa2304430}
}

@article{blazhenets2026-42441390,
  author  = {Blazhenets, Ganna and Soleimani-Meigooni, David N and Chiotis, Konstantinos and Allen, Isabel E and Rabinovici, Gil D and La Joie, Renaud and {Meta-Centiloid Study Group} and Apostolova, Liana G and others},
  title   = {{Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2026.13116},
  pmid    = {42441390},
  url     = {https://doi.org/10.1001/jama.2026.13116}
}

@article{ossenkoppele2025-40155777,
  author  = {Ossenkoppele, R. and Salvadó, G. and Janelidze, S. and Pichet Binette, A. and Bali, D. and Karlsson, L. and Palmqvist, S. and Mattsson-Carlgren, N. and Stomrud, E. and Therriault, J. and Rahmouni, N. and Rosa-Neto, P. and others},
  title   = {{Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials}},
  journal = {Nature Aging},
  year    = {2025},
  doi     = {10.1038/s43587-025-00835-z},
  pmid    = {40155777},
  url     = {https://doi.org/10.1038/s43587-025-00835-z}
}

@article{ayton2025-39495531,
  author  = {Ayton, S. and Barton, D. and Brew, B. and Brodtmann, A. and Clarnette, R. and Desmond, P. and Devos, D. and Ellis, K. A. and others},
  title   = {{Deferiprone in Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3733},
  pmid    = {39495531},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3733}
}

@article{bergeron2018-30255971,
  author  = {Bergeron, D. and Gorno-Tempini, M. L. and Rabinovici, G. D. and Santos-Santos, M. A. and Seeley, W. and Miller, B. L. and Pijnenburg, Y. and Keulen, M. A. and others},
  title   = {{Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia}},
  journal = {Annals of neurology},
  year    = {2018},
  doi     = {10.1002/ana.25333},
  pmid    = {30255971},
  url     = {https://doi.org/10.1002/ana.25333}
}

@article{ossenkoppele2022-36357681,
  author  = {Ossenkoppele, R. and Pichet Binette, A. and Groot, C. and Smith, R. and Strandberg, O. and Palmqvist, S. and Stomrud, E. and Tideman, P. and others},
  title   = {{Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline}},
  journal = {Nature medicine},
  year    = {2022},
  doi     = {10.1038/s41591-022-02049-x},
  pmid    = {36357681},
  url     = {https://doi.org/10.1038/s41591-022-02049-x}
}

@article{villemagne2013-23477989,
  author  = {Villemagne, V. L. and Burnham, S. and Bourgeat, P. and Brown, B. and Ellis, K. A. and Salvado, O. and Szoeke, C. and Macaulay, S. L. and others},
  title   = {{Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study}},
  journal = {The Lancet. Neurology},
  year    = {2013},
  doi     = {10.1016/s1474-4422(13)70044-9},
  pmid    = {23477989},
  url     = {https://doi.org/10.1016/s1474-4422(13)70044-9}
}

@article{salvado2025-40952756,
  author  = {Salvadó, G. and Janelidze, S. and Bali, D. and Dolado, A. O. and Therriault, J. and Brum, W. S. and Pichet Binette, A. and Stomrud, E. and Mattsson-Carlgren, N. and Palmqvist, S. and Coomans, E. M. and Teunissen, C. E. and others},
  title   = {{Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3217},
  pmid    = {40952756},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3217}
}

@article{wang2025-40156286,
  author  = {Wang, J. and Huang, S. and Lan, G. and Lai, Y. J. and Wang, Q. H. and Chen, Y. and Xiao, Z. S. and Chen, X. and Bu, X. L. and Liu, Y. H. and Zeng, F. and Zhang, L. and others},
  title   = {{Diagnostic accuracy of plasma p-tau217/Aβ42 for Alzheimer's disease in clinical and community cohorts}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70038},
  pmid    = {40156286},
  url     = {https://doi.org/10.1002/alz.70038}
}

@article{sperling2011-21514248,
  author  = {Sperling, R. A. and Aisen, P. S. and Beckett, L. A. and Bennett, D. A. and Craft, S. and Fagan, A. M. and Iwatsubo, T. and Jack, C. R. and others},
  title   = {{Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2011},
  doi     = {10.1016/j.jalz.2011.03.003},
  pmid    = {21514248},
  url     = {https://doi.org/10.1016/j.jalz.2011.03.003}
}

@article{villain2012-22628162,
  author  = {Villain, N. and Chételat, G. and Grassiot, B. and Bourgeat, P. and Jones, G. and Ellis, K. A. and Ames, D. and Martins, R. N. and others},
  title   = {{Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study}},
  journal = {Brain : a journal of neurology},
  year    = {2012},
  doi     = {10.1093/brain/aws125},
  pmid    = {22628162},
  url     = {https://doi.org/10.1093/brain/aws125}
}